Shandong Qiaodu Health Technology Co., Ltd., established on 2019-06-03, Business scope includes medical device production;Energy-saving technical service,technical consulting;Intelligent control products of urban Internet of things system,energy saving products,hardware design,to develop,Sales,Install,Commissioning and technical consultation,Technical Services,technology transfer;Energy statistics management and energy saving services;Development, design and after-sales service of intelligent cloud control management system integrating strong and weak electricity;General Electric Control Equipment,Design of Network Intelligent Controller,to develop,Production,Sales and Integration Services;Computer Management System Software,Hardware and Network System Design,Development and sales;Contract Energy Management;Nutrition and Health Consulting(non-medical);Computer System Integration Services;Skill Equipment Rental;car sales,lease;Leasing of medical equipment,repair;Professional contracting of electronic and intelligent engineering;Mechanical and electrical engineering construction general contracting;Professional contracting of building mechanical and electrical installation engineering;wholesale,retail:medical instruments(The operating permit),electronic product,Instrumentation,Non-specialized communication equipment,Equipment,metallic material,amorphous material,Office automation equipment,Computer software and auxiliary equipment;Import and export business and other legal,regulations,Items that are not prohibited by the State Council's decision and other regulations and do not require a business license.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Qingdao Huazhicao Pharmaceutical Technology Co., Ltd., established on 2015-09-06, Business scope includes medical technology development,technical consulting,Technology Promotion,Technical Services;Operating other general business items that can be operated without administrative approval.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jinan New Times Pharmaceutical Technology Co., Ltd., established on 2015-10-16, Business scope includes traditional Chinese medicine,Technology Development of Health Food,technology transfer,technical consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Yunnan Kangzhou Biotechnology Co., Ltd., established on 2012-11-12, Business scope includes licensed projects:Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Research and development of bio-based materials technology;Research and development of bio-based material polymerization technology;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;food sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Machinery sales;Mechanical equipment research and development;Instrument sales;electronics sales;Cosmetics Wholesale;Cosmetics Retail;General merchandise sales;Sales of hygiene products and single-use medical products;Personal Hygiene Sales;Medical Research and Experimental Development;Disinfectant sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Jinan Bangwen Pharmaceutical Technology Co., Ltd., established on 2015-02-15, Business scope includes medical technology development;Chinese medicine products,Healthy food,Technology development of washing products,Technical Consulting and Technical Services;translation service;office services(Does not include engraved seal);data processing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Foshan No. 1 People's Hospital, a subsidiary of Sun Yat-Sen University, is a company headquartered in Foshan, China. The firm provides healthcare services.

Jumpcan Pharmaceutical Co. Ltd., a subsidiary of Hubei Jumpcan Pharmaceutical Co., Ltd., is a Chinese company located in Taixing that manufactures and develops pharmaceutical products. Long Xiang Cao is currently the CEO of the firm. Hubei Jumpcan Pharmaceutical Co., Ltd. acquired Jumpcan Pharmaceutical Co. Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million.

Beijing Huare Power New Energy Information Technology Co., Ltd., established on 2001-07-11, Business scope includes technology development,technology transfer,technical consulting,Technical Services,Technology Promotion;Sales of machinery and equipment,Instrumentation.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Guangxi Xinye Biotechnology Co., Ltd., established on 2012-05-16, Business scope includes general items:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Refrigeration,Air Conditioning Equipment Sales;Sales of hygiene products and single-use medical products;Cosmetics Retail;Cosmetics Wholesale;General merchandise sales;Sales of labor protection products;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of bio-based materials;Disinfectant sales(Free of Hazardous Chemicals);production of agricultural products,Sales,processing,transportation,Storage and other related services;food sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Sales of infant formula milk powder and other infant formula food;Sales of formula food for special medical purposes;New material technology research and development;General Equipment Repair;rental service(Licensed rental services not included);Special Equipment Repair;electronic,Mechanical equipment maintenance(No special equipment);software development;software sales;Information Technology Consulting Services;General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval);business training(Does not include education and training,Vocational skills training and other licensed training);Food Additive Sales;Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of renewable resources;Sales of daily chemical products;Extraction of marine bioactive substances,purification,Synthesis technology research and development;Engineering and Technology Research and Experimental Development;food,liquor,Manufacture of special equipment for beverage and tea production;Information system operation and maintenance services;Data processing and storage support services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Haimen Mingyang Industrial Co., Ltd., established on 2007-06-20, Business scope includes investment management of industrial construction projects;Industrial incubator;Investments in urban infrastructure and water networks;Landscaping project,Earthwork,Construction of water conservancy projects;Electrical Equipment,Wujinjiaodian,Wholesale of building decoration and decoration materials,retail;Acquisition of agricultural and sideline products,Sales;property management;Own house rental;Sewage pipeline and water purification equipment installation,repair;Mahogany handicraft manufacturing,processing,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Yudu Medical Technology Co., Ltd., established on 2006-12-07, The scope of business includes the operation of medical equipment,Engaged in technology development in the field of medical science and technology,Technical Services. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Hubei Furen Jinshen Pharmaceutical Co., Ltd., established on 2001-03-26, Business range includes tablet,Granules,hard capsule,mixture(Contains traditional Chinese medicine extraction workshop),oral solution,Syrup production,Sales.(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Shanghai Feilei International Trade Co., Ltd., established on 2008-10-21, The scope of business includes import and export of goods and technology,Re-export trade,Trade and trade agency between enterprises in the region,Simple commercial processing and business consulting services in the region,Warehousing business in the region(In addition to dangerous goods),Leasing business of self-owned property and equipment(Not to engage in financial leasing),Medical Equipment and Consumables(The operating permit,see license),clothing,Office Supplies,electronic product,Communication equipment,Instrumentation,Computer hardware and software and accessories,building decoration materials,Sales of daily necessities. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

NicOx is a biopharmaceutical company, engages in the development and commercialization of nitric oxide (NO)-donating drugs primarily for inflammation and cardio-metabolic diseases. The company's primary products candidates include Naproxcinod, a Phase III product candidate for the treatment of osteoarthritis; and NCX 6560, a NO-donating compound for the treatment of cardiovascular diseases, which is in phase I clinical trials. Its product portfolio comprise PF-03187207 for the treatment of glaucoma, TPI 1020 for the treatment of respiratory disorders, and NCX 1510 for allergic rhinitis, which are in Phase II clinical trials; and NO-donating antihypertensives, which is in phase I clinical trials for the treatment of hypertension. The company's product pipeline also include NCX 1047, which is in preclinical stage of development for treating a range of skin disorders, such as atopic dermatitis, psoriasis, and seborrheic dermatitis; and NO-donors for diabetic retinopathy, cardiometabolic, inflammation, and pain. It has research and co-development agreement with Orexo AB to identify and develop compounds for the treatment of airway diseases; license and development agreement with TOPIGEN Pharmaceuticals Inc. The company also has agreements with Grupo Ferrer Internacional SA for the research, development, and marketing of NO-donating anti-inflammatory drugs for the treatment of dermatological diseases; Pfizer Inc to identify nitric oxide-donating compounds for diabetic retinopathy; and Merck & Co., for the development of new antihypertensive drugs using NicOx' nitric oxide-donating technology. NicOx S.A. was founded in 1996 and is headquartered in Sophia Antipolis, France.

Xi'an Tongpao Enterprise Management Group Co., Ltd., established on 2020-04-14, Business scope includes general items:Corporate Headquarters Management;business management;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Consulting Service(Not including licensing information consulting services);Health Consulting Services(Does not include medical services);Standardized service;HR Services(Excludes job brokerage activities,Labor dispatch service);Remote Health Management Services;Biomass energy resource database information system platform;Research and development of bio-based materials technology;Manufacturing of bio-based materials;Sales of bio-based materials;Consulting and planning service;Apparel research and development;Biomass Energy Technology Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Anhui Provincial Hospital, a subsidiary of Province of Anhui, is a Chinese company located in Hefei. The firm provides health related services.